Background Despite guideline‐recommended use of oral anticoagulation (OAC) for stroke prevention in atrial fibrillation (AF), OAC medication adherence among patients with AF in the United States ranges from 47% to 82%. To characterize potential causes of nonadherence, we analyzed associations between community and individual social risk factors and OAC adherence for stroke prevention in AF. Methods and Results A retrospective cohort analysis of patients with AF was conducted using the IQVIA PharMetrics Plus claims data from January 2016 to June 2020, and 3‐digit ZIP code‐level social risk scores were calculated using American Community Survey and commercial data. Logistic regression models evaluated associations between community social det...
Background:Patients' knowledge regarding their oral anticoagulant (OAC) treatment for stroke prevent...
AIMS : Studies on adherence and persistence with non-vitamin K oral anticoagulant (NOAC) treatment h...
Objective: The overall aim of this dissertation was to provide a better understanding of adherence ...
Background:Patient clinical factors and social determinants of health (SDOH) are associated with...
Abstract Background Atrial fibrillation (AF) patients are routinely prescribed medications to preven...
BACKGROUND: Current risk scores that are solely based on clinical factors have shown modest predicti...
Background: A growing body of literature now exists examining associations between social determina...
BackgroundNon-adherence to medications is common in patients with atrial fibrillation (AF), increasi...
[[abstract]]Objective To investigate anticoagulant adherence and its associated factors, including d...
Background Despite simpler regimens than vitamin K antagonists (VKAs) for stroke prevention in atria...
Background: The aim of this study was to investigate the proportion of patients who have suboptimal ...
Background Non-vitamin K antagonist oral anticoagulants (NOAC) have superior safety and comparable e...
[[abstract]]Objective: To investigate anticoagulant adherence and its associated factors, including ...
Aim. To assess adherence to new oral anticoagulants (NOAC) or warfarin therapy and to study the fact...
Background:Patients' knowledge regarding their oral anticoagulant (OAC) treatment for stroke prevent...
AIMS : Studies on adherence and persistence with non-vitamin K oral anticoagulant (NOAC) treatment h...
Objective: The overall aim of this dissertation was to provide a better understanding of adherence ...
Background:Patient clinical factors and social determinants of health (SDOH) are associated with...
Abstract Background Atrial fibrillation (AF) patients are routinely prescribed medications to preven...
BACKGROUND: Current risk scores that are solely based on clinical factors have shown modest predicti...
Background: A growing body of literature now exists examining associations between social determina...
BackgroundNon-adherence to medications is common in patients with atrial fibrillation (AF), increasi...
[[abstract]]Objective To investigate anticoagulant adherence and its associated factors, including d...
Background Despite simpler regimens than vitamin K antagonists (VKAs) for stroke prevention in atria...
Background: The aim of this study was to investigate the proportion of patients who have suboptimal ...
Background Non-vitamin K antagonist oral anticoagulants (NOAC) have superior safety and comparable e...
[[abstract]]Objective: To investigate anticoagulant adherence and its associated factors, including ...
Aim. To assess adherence to new oral anticoagulants (NOAC) or warfarin therapy and to study the fact...
Background:Patients' knowledge regarding their oral anticoagulant (OAC) treatment for stroke prevent...
AIMS : Studies on adherence and persistence with non-vitamin K oral anticoagulant (NOAC) treatment h...
Objective: The overall aim of this dissertation was to provide a better understanding of adherence ...